Loss of heterozygosity and human telomerase reverse transcriptase (hTERT) expression in bronchial mucosa of heavy smokers

被引:9
作者
Capkova, Linda
Kalinova, Marketa
Krskova, Lenka
Kodetova, Daniela
Petrik, Frantisek
Trefny, Martin
Musil, Jaromir
Kodet, Roman
机构
[1] Univ Hosp Motol, Dept Pneumol, Prague 15006 5, Czech Republic
[2] Charles Univ Prague, Fac Med 2, Dept Pathol & Mol Med, CR-11636 Prague 1, Czech Republic
关键词
loss of heterozygosity; telomerase; hTERT mRNA expression; precancerous lesions; heavy smokers;
D O I
10.1002/cncr.22683
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BACKGROUND. Lung carcinogenesis is a multistep process of accumulation of genetic changes, including loss of heterozygosity (LOH), and precedes phenotypic transformation of the bronchial mucosa. The activity of telomerase, correlating with the hTERT mRNA expression, is detectable in a majority of neoplasms. In this study, the frequency of LOH and hTERT expression in bronchial mucosa of heavy smokers in bronchoscopic biopsies was analyzed. METHODS. LOH was examined in 122 bronchial specimens from 81 smokers (67 normal mucosa/bronchitis, 12 squamous metaplasia, 28 dysplasia, 15 bronchogenic carcinoma specimens) by polymerase chain reaction (PCR) and capillary electrophoresis by using 7 fluorescence-labeled markers matching 5 chromosomal regions. hTERT expression was analyzed in 87 specimens (45 normal mucosa/bronchitis, 12 squamous metaplasia, 18 dysplasia, 12 bronchogenic carcinoma specimens) by real-time quantitative reverse-transcription PCR. RESULTS. LOH was detected in at least I chromosomal region in 51 of 122 (41.8%) specimens; the incidence in normal bronchial mucosa and preneoplastic lesions was similar (20%-40%); a substantial rise (87%) occurred in carcinomas. The median normalized hTERT(N) values were 6.67 in normal epithelium/chronic bronchitis, 18.38 in squamous metaplasia, 13.31 in epithelial dysplasia, and 75.46 in carcinomas. These results were significantly different (P =.0036). With an increasing number of LOH, the median value of hTERTN expression rose, but hTERT was expressed also in tissue samples without any LOH detection. CONCLUSIONS. Results indicated that hTERT expression, together with LOH, represent early events in lung carcinogenesis, as both were detected in precancerous lesions and in normal epithelium of heavy smokers.
引用
收藏
页码:2299 / 2307
页数:9
相关论文
共 39 条
[1]   Expression of human telomerase subunit genes in primary lung cancer and its clinical significance [J].
Arinaga, M ;
Shimizu, S ;
Gotoh, K ;
Haruki, N ;
Takahashi, T ;
Takahashi, T ;
Mitsudomi, T .
ANNALS OF THORACIC SURGERY, 2000, 70 (02) :401-405
[2]   Focus on research: Telomeres, telomerase, and human disease [J].
Artandi, Steven E. .
NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (12) :1195-1197
[3]   CHANGES IN BRONCHIAL EPITHELIUM IN RELATION TO CIGARETTE-SMOKING, 1955-1960 VS 1970-1977 [J].
AUERBACH, O ;
HAMMOND, EC ;
GARFINKEL, L .
NEW ENGLAND JOURNAL OF MEDICINE, 1979, 300 (08) :381-386
[4]   Telomerase activity: A biomarker of cell proliferation, not malignant transformation [J].
Belair, CD ;
Yeager, TR ;
Lopez, PM ;
Reznikoff, CA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (25) :13677-13682
[5]  
Bijwaard KE, 2001, CLIN CHEM, V47, P195
[6]   Extension of life-span by introduction of telomerase into normal human cells [J].
Bodnar, AG ;
Ouellette, M ;
Frolkis, M ;
Holt, SE ;
Chiu, CP ;
Morin, GB ;
Harley, CB ;
Shay, JW ;
Lichtsteiner, S ;
Wright, WE .
SCIENCE, 1998, 279 (5349) :349-352
[7]   Early detection of lung cancer: role of biomarkers [J].
Brambilla, C ;
Fievet, F ;
Jeanmart, M ;
de Fraipont, F ;
Lantuejoul, S ;
Frappat, V ;
Ferretti, G ;
Brichon, PY ;
Moro-Sibilot, D .
EUROPEAN RESPIRATORY JOURNAL, 2003, 21 :36S-44S
[8]  
Brambilla E, 1999, CLIN CANCER RES, V5, P243
[9]   Telomerase activity is restored in human cells by ectopic expression of hTERT (hEST2), the catalytic subunit of telomerase [J].
Counter, CM ;
Meyerson, M ;
Eaton, EN ;
Ellisen, LW ;
Caddle, SD ;
Haber, DA ;
Weinberg, RA .
ONCOGENE, 1998, 16 (09) :1217-1222
[10]  
Gafà R, 2000, CANCER, V89, P2025, DOI 10.1002/1097-0142(20001115)89:10<2025::AID-CNCR1>3.0.CO